Stimulating pharmaceutical research and development for neglected diseases
- 10 October 2002
- journal article
- Published by Elsevier in Health Policy
- Vol. 64 (1) , 75-88
- https://doi.org/10.1016/s0168-8510(02)00138-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Equity and health sector reforms: can low-income countries escape the medical poverty trap?The Lancet, 2001
- Measuring the efficiency of health systemsBMJ, 2001
- The Major Infectious Diseases in the World — To Treat or Not to Treat?New England Journal of Medicine, 2001
- Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1The Lancet, 2001
- Science or marketing at WHO? A commentary on ‘World Health 2000’Health Economics, 2001
- Ten recommendations to improve use of medicines in developing countriesHealth Policy and Planning, 2001
- Prospects for Vaccines to Protect Against AIDS, Tuberculosis, and MalariaPublished by American Medical Association (AMA) ,2001
- Editorial: Drugs for 'neglected diseases': a bitter pillTropical Medicine & International Health, 2000
- Access to Essential Drugs in Poor CountriesA Lost Battle?JAMA, 1999
- The Evidence Base on the Cost-Effectiveness of Malaria Control Measures in AfricaHealth Policy and Planning, 1999